Primary Antibodies
Secondary Antibodies
Proteins & Peptides
ELISA Kits
About Us
Contact Us
Antibodies.com Logo Antibodies.com Logo
Sign In/Register
0
ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Anti-M-CSF Antibody [DMC437] (PE) (A334043)

Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
This product is discontinued

Recombinant Anti-M-CSF Antibody [DMC437] (PE) (A334043) has been discontinued and is no longer available.

View all M-CSF Antibodies.

  • Specifications

Name
Anti-M-CSF Antibody [DMC437] (PE)
Description
Recombinant chimeric monoclonal [DMC437] antibody to M-CSF (PE).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Rabbit / Human
Clonality
Monoclonal
Clone ID
DMC437
Isotype
IgG1
Conjugate

PE

Excitation: 565nm, Emission: 578nm

Purification
Affinity chromatography.
Concentration
Lot Specific
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.05% Proclin 300 and 1% BSA.
Storage
Store at 4°C. Do not freeze!
General Notes
This antibody is a recombinant rabbit chimeric monoclonal antibody containing human IgG1 Fc.
Synonyms
CSF-1, CSF1, Lanimostim, Macrophage colony-stimulating factor 1, MCSF, PG-M-CSF, Proteoglycan macrophage colony-stimulating factor
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Alternative products to Anti-M-CSF Antibody [DMC437] (PE) (A334043)

Antibodies.com Image Placeholder - Discover more for less
A334042
Lacnotuzumab Biosimilar - Anti-M-CSF Antibody (PE)
Recombinant humanized monoclonal antibody to M-CSF (PE) for Flow Cytometry.
Antibodies.com Image Placeholder - Discover more for less
A334042
Lacnotuzumab Biosimilar - Anti-M-CSF Antibody (PE)
Recombinant humanized monoclonal antibody to M-CSF (PE) for Flow Cytometry.

Proteins predicted to interact with M-CSF

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.7% Relevancy Score
96.4% Relevancy Score
94.2% Relevancy Score
94.1% Relevancy Score
93.3% Relevancy Score
91.8% Relevancy Score
91.3% Relevancy Score
91.2% Relevancy Score